| Ytd | -70.11% | |
| 1y | -87.26% |
| Open | 3.20 | Prev Close | 3.21 | Low | 3.16 | High | 3.28 | Mkt Cap | 38.41M |
| Vol | 73.39K | Avg Vol | 296.37K | EPS | -0.69 | P/E | -4.69 | Forward P/E | -0.86 |
| Beta | 6.95 | Short Ratio | 1.76 | Inst. Own | 4.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 3.54 | 200-d Avg | 7.22 | 1yr Est | 0.00 |
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
The granted patent includes claims directed to the proprietary IHL-42X composition and its associate
Incannex Healthcare Inc. (NASDAQ:IXHL) ("Incannex" or the "Company"), a clinical-sta
Alliance Global Partners analyst James Molloy initiates coverage on Incannex Healthcare (NASDAQ:I
Incannex Healthcare (NASDAQ:IXHL) reported quarterly losses of $(0.35) per share which beat the anal
Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innova
Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing combin
U.S. stocks declined, with Dow Jones falling over 500 points while NASDAQ and S&P 500 also dropp
Incannex shares drop after announcing a $10 million stock offering to fund its IHL-42X sleep apnea s
U.S. stocks down, Dow falls 500+ points. Energy shares up 0.4%, financial stocks down 1.4%. Jobless
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innov
Incannex Healthcare Inc. (NASDAQ:IHXL), ("Incannex" or the "Company") a clinical-sta
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innov
Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innova
MELBOURNE, Australia and NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDA
MELBOURNE, Australia and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDA
During the session on Thursday, 461 stocks hit new 52-week lows.
GAINERS: Red White & Bloom Brands (OTC: RWBYF) shares closed up 300.00% at $0.04
On Thursday, 588 stocks hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Monday, 147 stocks hit new 52-week lows.